Biocon Share Price
Small Cap | Pharmaceuticals and health care | NSE: BIOCON | BSE: 532523
₹361.85 
-15.35 (-4.07 %)
Last Updated: 11 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 376.00
High (₹) 378.95
Low (₹) 360.00
Prev. Close (₹) 377.20
Volume 99,386
VWAP (₹) 391.24
ROCE (%) 6.37
Industry P/E 47.86
TTM P/E 54.01
P/B Ratio 1.72
Market Cap (₹) Cr.43,461.72
Dividend Yield (%)0.14
EPS (₹) 8.54
ROE4.06%
Sales Growth (%) 32.05
Profit Growth (%)70.62
Day Range
378.95378.95
52 Week Range
244.40404.60
Historical Returns
Returns (6M)
6.22 %
Returns (1Y)
35.65 %
Returns (3Y)
-8.03 %
Returns (5Y)
17.94 %
Returns (6M)
6.22 %
Returns (1Y)
35.65 %
Returns (3Y)
-8.03 %
Returns (5Y)
17.94 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (120.67%) TTM EPS Growth
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 120.67% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
Technicals
Technical Rating
BEARISHRSI 48.34
MFI 58.15
ATR 15.17
Commodity Channel Index 53.87
ROC125 13.92
ROC21 4.05
Williams %R -24.62
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 395.26 | 404.13 | 409.16 | 390.23 | 381.36 | 376.33 | 367.46 |
| Week Ago | 373.46 | 384.38 | 397.96 | 359.88 | 348.96 | 335.38 | 324.46 |
| Month Ago | 394.09 | 405.82 | 422.64 | 377.27 | 365.54 | 348.72 | 336.99 |
EMA & SMA
361.85
Current Price
Bullish Moving Averages
4
Bearish Moving Averages
16
5 Day 375.79
9 Day 369.27
10 Day 369.30
12 Day 377.80
14 Day 377.18
20 Day 380.95
26 Day 377.49
50 Day 369.09
100 Day 356.77
200 Day 346.30
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 18 Jan, 2024 | ₹279.80 | 4,69,049 | BSE |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 18 Jan, 2024 | ₹279.80 | 4,69,049 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 25 Oct, 2022 | ₹270.10 | 4,66,252 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 25 Oct, 2022 | ₹270.10 | 4,66,252 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 17 Oct, 2022 | ₹261.30 | 7,32,649 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 17 Oct, 2022 | ₹261.30 | 7,32,649 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 11 Oct, 2022 | ₹277.40 | 5,37,316 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 11 Oct, 2022 | ₹277.40 | 5,37,316 | BSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 19 Sept, 2022 | ₹291.25 | 3,65,477 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 19 Sept, 2022 | ₹291.25 | 3,65,477 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 10 Jun, 2024 | SIVANANDAM K Revised | Pledge | ₹256.6000272925764192139737991 | 7,328 | BSE |
| 05 Apr, 2024 | NEHAL VORA | Pledge | ₹256.5999967651673217202840183 | 61,827 | BSE |
| 04 Apr, 2024 | SIVANANDAM K | Pledge | ₹256.6000272925764192139737991 | 7,328 | BSE |
| 02 Apr, 2024 | KIRAN KUMAR GANDHIRAJAN | Disposal | ₹264.3439843984398439843984398 | 19,998 | BSE |
| 02 Apr, 2024 | AKHILESH NAND | Disposal | ₹260.55 | 11,000 | BSE |
| 25 Mar, 2024 | SUMIT RAY | Acquisition | ₹251.20 | 2,000 | BSE |
| 25 Mar, 2024 | RAHUL AGRAWAL | Acquisition | ₹251.20 | 2,000 | BSE |
| 19 Mar, 2024 | SHASHI KANT TIWARI | Acquisition | ₹251.6500294464075382803297998 | 6,792 | BSE |
| 05 Mar, 2024 | Maneesh Ghildyal | Disposal | ₹283.00 | 5,000 | BSE |
| 05 Mar, 2024 | Maneesh Ghildyal | Disposal | ₹275.80 | 1,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 16 May, 2024 | Rs.0.5000 per share(10%)Final Dividend | 05 Jul, 2024 | 05 Jul, 2024 |
| 24 May, 2023 | Rs.1.5000 per share(30%)Final Dividend | 07 Jul, 2023 | 07 Jul, 2023 |
| 28 Apr, 2022 | Rs.0.5000 per share(10%)Final Dividend | 30 Jun, 2022 | 01 Jul, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 07 Feb, 2025 | BSE India | Management of the Company is scheduled to meet with Investors on February 13, 2025 and February 17, 2025 in Mumbai |
| 07 Feb, 2025 | NSE India | Biocon Limited has informed the Exchange about Schedule of meet |
| 07 Feb, 2025 | BSE India | Management of the Company is scheduled to meet with Investors on February 13, 2025 and February 15, 2025 in Mumbai |
| 07 Feb, 2025 | BSE India | Transcript of Q3 FY 25 Earnings Call |
| 07 Feb, 2025 | NSE India | Biocon Limited has informed the Exchange about Transcript |
| 06 Feb, 2025 | BSE India | Press Release |
| 06 Feb, 2025 | NSE India | Biocon Limited has informed the Exchange regarding a press release dated February 06, 2025, titled ""Equillium Inc. and Biocon Limited Announce Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis"". |
| 03 Feb, 2025 | NSE India | Biocon Limited has informed the Exchange regarding ''Corporate Presentation''. |
| 01 Feb, 2025 | NSE India | Biocon Limited has informed the Exchange about Copy of Newspaper Publication |
| 01 Feb, 2025 | BSE India | Intimation under Regulation 30 of SEBI Listing Regulations |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 06 Jan, 2025 | 30 Jan, 2025 |
| Others | Inter-alia, to consider 1. Raising of Funds through issuance of Commercial Papers (CPs) or through any other mode on private placement basis. | 24 Jan, 2025 | 27 Jan, 2025 |
| Quarterly Results | -- | 04 Oct, 2024 | 30 Oct, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 08 Aug, 2024 |
| Audited Results & Final Dividend | -- | 15 Apr, 2024 | 16 May, 2024 |
| Quarterly Results | -- | 11 Jan, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 10 Oct, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 24 Jul, 2023 | 10 Aug, 2023 |
| Audited Results & Final Dividend | -- | 24 Apr, 2023 | 23 May, 2023 |
| Others | To consider, Fund Raising. | 25 Apr, 2023 | 26 Apr, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Biocon
Biocon is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 2127.30 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1978
Managing Director
Mr. Siddharth Mittal
NSE Symbol
BIOCON
Biocon Management
| Name | Designation |
|---|---|
| Ms. Kiran Mazumdar Shaw | Executive Chairperson |
| Mr. Siddharth Mittal | Managing Director & CEO |
| Prof. Ravi Rasendra Mazumdar | Non Exe.Non Ind.Director |
| Mr. Eric Vivek Mazumdar | Non Exe.Non Ind.Director |
| Mr. Meleveetil Damodaran | Independent Director |
| Mr. Bobby Kanubhai Parikh | Independent Director |
| Mr. Naina Lal Kidwai | Independent Director |
| Ms. Rekha Mehrotra Menon | Independent Director |
| Mr. Nicholas Robert Haggar | Independent Director |
| Mr. Atul Dhawan | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,699.75  ₹1,732.10(-1.87%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,946.75  ₹5,938.80(0.13%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,453.15 ₹1,458.85(-0.39%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,450.30 ₹2,502.05(-2.07%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,209.80 ₹1,220.95(-0.91%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Biocon
What is the share price of Biocon?
The share price of Biocon on 11 Feb, 2025 is ₹ 361.85.
What is 52W high and 52W low share price of Biocon?
The highest and lowest 52W share prices of Biocon are ₹ 395.650 and ₹ 244.400
What is the market cap of Biocon?
The market capitalization of Biocon as of 11 Feb, 2025 is ₹ 43,461.72 Crores
What is the P/E ratio of Biocon?
The current P/E ratio of Biocon as of 11 Feb, 2025 is 47.86
What is the PB ratio of Biocon?
The PB ratio of Biocon as of 11 Feb, 2025 is 1.72
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)